Mifepristone Market Overview
The Mifepristone Market was valued at USD 700 million in 2024 and is projected to reach USD 1,200 million by 2035, growing at a CAGR of 4.4%. Mifepristone is a progesterone receptor antagonist primarily used for medical abortion and the management of Cushing's syndrome. The market encompasses various dosage forms including tablets, injectables, and injections, with tablets dominating due to...
0 Comments 0 Shares 96 Views 0 Reviews